Clinical trial
Efficacy of the Combination of Memantine in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Young Patients to Previous Combination Therapy of Quetiapine Plus Lithium or Quetiapine Plus Aripiprazole
NCT02630888 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Combination of Memantine in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Young Patients to Previous Combination Therapy of Quetiapine Plus Lithium or Quetiapine Plus Aripiprazole
- Lead sponsor
- University of Sao Paulo
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- September 30, 2020
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.